Cat. #157984
OAW42A cell line
Cat. #: 157984
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Availability: 8-10 weeks
Organism: Human
Disease: Cancer
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Martin Clynes
Institute: Dublin City University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: OAW42A cell line
- Cancer: Gynaecologic cancer
- Cancers detailed: Ovarian cystadenocarcinoma
- Research fields: Cancer;Drug development
- Tool sub type: Continuous
- Parental cell: OAW42 (ECACC #85073102)
- Organism: Human
- Disease: Cancer
- Growth properties: monolayer
- Description: resistant to doxorubicin i.e. adriamycin. Epithelial model
- Production details: Developed from an OAW42 population with spontaneous resistance to doxorubicin - then made more resistant by prolonged exposure with 0.85 ug/ml doxorubicin
- Biosafety level: 1
- Recommended controls: OAW42 parental line
Applications
- Application notes: Epithelial model The original parent cell line (OAW42) is available from ECACC at https://www.phe-culturecollections.org.uk/products/celllines/generalcell/detail.jsp?refId=85073102&collection=ecacc_gc . If the progeny of the original batch of the parental cell line used to make this derivative cell line at Dublin City University is of interest...
Handling
- Format: Frozen
- Growth medium: DMEM/Ham's F12, 10% FCS. Split 1:3 to 1:6, medium change 2-3 times weekly. Freezing method: 5% DMSO in FBS
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Storage conditions: Liquid Nitrogen
- Mycoplasma free: Yes
References
- NicAmhlaoibh et al. 1999. Int J Cancer. 82(3):368-76. PMID: 10399954.
- Moran et al. 1997. Eur J Cancer. 33(4):652-60. PMID: 9274450.
